Dupont Capital Management Corp Morphic Holding, Inc. Transaction History

Dupont Capital Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	BUY	$19.74 - $43.01 $48,362 - $105,374	2,450 Added 65.93%	6,166 $134,000
Q1 2022 Apr 27, 2022	SELL	$36.25 - $52.02 $11,926 - $17,114	-329 Reduced 8.13%	3,716 $149,000
Q4 2021 Jan 31, 2022	SELL	$43.27 - $65.72 $69,794 - $106,006	-1,613 Reduced 28.51%	4,045 $192,000
Q3 2021 Nov 03, 2021	SELL	$53.61 - $67.5 $42,888 - $54,000	-800 Reduced 12.39%	5,658 $320,000
Q2 2021 Jul 30, 2021	BUY	$45.13 - $64.99 $291,449 - $419,705	6,458 New	6,458 $371,000

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.